When blood cancer in children progresses particularly aggressively, it is often due to a genetic defect: a gene fusion, such as the NUP98 fusion oncoprotein, which drives uncontrolled cell growth. Standard therapies are often ineffective against…
Continue Reading
News Source: medicalxpress.com
Leave a Reply